Cbd Life Sciences

CBDL · OTC

$0.0001−$0.0001 (−50.00%)TodayMarket open · · Delayed 15 min
Prev close $0.0002

Latest news

  • Press releaseACCESS Newswire

    CBD Life Sciences Inc. (CBDL) CEO Lisa Nelson Interviews With The Morning Show

  • Press releaseACCESS Newswire

    CBD Life Sciences Inc. (CBDL) Secures Landmark Agreement with Bronx Powerhouse Dispensary Smoking Scholars

  • Press releaseACCESS Newswire

    CBD Life Sciences Inc. (CBDL) Announces President Trump Confirms Marijuana Rescheduling Is Under Consideration

  • Press releaseACCESS Newswire

    CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Columbian Company

  • Press releaseACCESS Newswire

    CBD Life Sciences Inc. (CBDL) Powers Forward with Disruptive Brain-Boosting Mushroom Applications

  • Press releaseACCESSWIRE

    CBD Life Sciences Inc. (CBDL) Announces Open Market Share Buyback

  • Press releaseACCESSWIRE

    CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary

  • Press releaseACCESSWIRE

    CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine

  • Press releaseACCESSWIRE

    CBD Life Sciences, Inc. (CBDL) Positioned for Unmatched Growth as Trump Welcomes Weed Legalization and Federal Rescheduling

  • Press releaseGlobe Newswire

    CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push

  • Press releaseACCESSWIRE

    CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push

  • Press releaseACCESSWIRE

    CBD Life Sciences, Inc. Expands Footprint With Proposed Strategic Acquisition of Interest in Two New York Cannabis Dispensaries

  • Press releaseACCESSWIRE

    CBD Life Sciences, Inc. (CBDL) Welcomes Major Political Endorsement for Cannabis Legalization

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.